1098P Mechanisms of Recurrence Following Mrna-4157 (V940) Plus Pembrolizumab or Pembrolizumab Alone in Resected Melanoma from the Mrna-4157-p201 (KEYNOTE-942) Trial
Annals of Oncology(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Annals of Oncology(2024)